FDA says scarcity of weight reduction medicine manufactured by Eli Lilly is over
The USA Meals and Drug Administration says the scarcity of Eli Lilly’s Zepbound and Mounjaro medicine has been resolved and that specialty pharmacies and on-line firms must cease promoting off-brand variations of the weight-loss medicine. The FDA has issued warnings towards the off-brand variations, citing security considerations. “FDA is conscious that some sufferers and well
Read More